Hyperkalemia diagnostic study of choice

Jump to navigation Jump to search


Hyperkalemia Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hyperkalemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hyperkalemia diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hyperkalemia diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hyperkalemia diagnostic study of choice

CDC on Hyperkalemia diagnostic study of choice

Hyperkalemia diagnostic study of choice in the news

Blogs on Hyperkalemia diagnostic study of choice

Directions to Hospitals Treating Hyperkalemia

Risk calculators and risk factors for Hyperkalemia diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jogeet Singh Sekhon

Overview

Serum potassium is the gold standard test for the diagnosis of hyperkalemia. Pseudohyperkalemia needs to be ruled out whenever hyperkalemia is diagnosed. Pseudohyperkalemia is defined when serum potassium concentration exceeds that of plasma. Different etiologies of hyperkalemia can be assessed by using the diagnostic criteria.

Diagnostic Study of Choice

Study of choice

Serum potassium is the gold standard test for the diagnosis of hyperkalemia.[1]

There are two methods to determine serum potassium   :

  • Ion-specific electrode (ISE) potentiometry

ISE potentiometry has two different subtypes: direct (undiluted) and indirect (diluted).

  • Direct ISE measures plasma potassium directly from a whole-blood sample and it's not associated with pseudohyperkalemia.
  • FES or indirect ISE requires sample dilution before assay and both are associated with pseudohyperkalemia.

Pseudohyperkalemia

Pseudohyperkalemia is defined when serum potassium concentration exceeds that of plasma without any symptoms of hyperkalemia.

  • It usually occurs when potassium moves out of cells during blood specimen collection or during centrifugation of the sample.
  • Other causes are thrombocytosis, leukocytosis and erythrocytosis.
  • To rule out pseudohyperkalemia we need to do the following :[2]
    • Repeat the blood sample.
    • Complete blood count to rule out thrombocytosis, erythrocytosis and leukocytosis.
    • Measurement of plasma potassium and whole blood potassium.
Diagnostic results

The finding on performing the diagnostic test that confirms hyperkalemia

  • Serum Potassium level more than 5.1 meq/L.

Common Diagnostic Studies

The serum potassium must be performed when:

Depending on the history and results of the above mentioned tests,other tests that can be performed for evaluating the cause of hyperkalemia.

Sequence of diagnostic studies

  • Serum Potassium measurement.
  • ECG-it denotes the urgency of the treatment.
  • Renal function test.
    • Serum BUN and creatinine are measured.
    • Since creatinine levels are dependent on muscle mass so GFR measurement is preferred.
  • Urine potassium,sodium and osmolality measurement.
    • Urine potassium measurement.
    • Urine potassium <20meq/L denotes impaired excretion of potassium and denotes renal cause of hyperkalemia.
    • Urine potassium .40meq/L denotes adequate excretion of potassium and excludes renal cause of hyperkalemia.
    • Urine sodium <20meq/L denotes decreased sodium delivery to the distal tubules which decreases potassium secretion.
    • Urine osmolarity-measuring urine osmolarity is very important for accurate measurement of urine potassium as concenterated or dilute urine will alter the urine potassium concenteration.
  • Serum osmolarity.
    • High serum osmolarity(>295 mosm/kg) may result in extracellular shift of potassium .
  • Blood gas analysis .[3]
    • Decreased serum pH causes extracellular shift of potassium into the blood.
  • Transtubular Potassium gradient.
    • It calculates the ratio of amount potassium in the collecting duct of kidneys with the amount of potassium in the peritubular capillaries.
    • It indicates the activity of aldosterone on kidneys in regulation of potassium levels.
    • TTG calculation-( Urine K+ x Serum osmolarity)/(serum K+ x Urine omolarity).
    • TTG <3 suggests lack of aldosterone effect on collecting ducts causing decreased excretion of potassium.
    • TTG >7 suggest adequate effect of aldosterone in a case of hyperkalemia.
    • If TTG suggest aldosterone etiology then further testing done.
  • Aldosterone levels
  • Renin levels [4]


Diagnostic criteria

 
 
 
 
 
 
 
 
 
 
 
 
 
Potassium >5.1meq/L
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ECG
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If no changes,rule out pseudohyperkalemia
 
If changes present then start urgent treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Urine sodium <25 meq/L
 
 
 
 
 
 
urine sodium >25 meq/L
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ARF
CKD
Heart failure
Volume depletion
 
Decreased K+secretion(Urine K+<20meq/L
 
 
 
 
 
 
 
Transcellular shift(measure serum osmolarity and pH)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Low aldosterone(TTG<3)
 
 
 
 
 
Normal aldosterone(TTG>7)
 
 
 
 
Diabetic ketoacidosis
Metabolic acidosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Low renin
 
Normal renin
 
 
 
Tissue breakdown
Pseudohypoaldosternism type 1 and type 2
Type 1 RTA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interstital nephritis
Obstructive uropathies
Diabetic nephropathy
ACE inhibitors,Angiotensin 2 receptors
 
Primary hypoaldosteronism
Congenital adrenal hyperplasia
Aldosterone receptor antagonists
RTA type 4
 
 
 
 
 
 
 
 


References

  1. Lehnhardt A, Kemper MJ (2011). "Pathogenesis, diagnosis and management of hyperkalemia". Pediatr Nephrol. 26 (3): 377–84. doi:10.1007/s00467-010-1699-3. PMC 3061004. PMID 21181208.
  2. Šálek T (2018). "Pseudohyperkalemia - Potassium released from cells due to clotting and centrifugation - a case report". Biochem Med (Zagreb). 28 (1): 011002. doi:10.11613/BM.2018.011002. PMC 5806620. PMID 29472808.
  3. SCRIBNER BH, FREMONT-SMITH K, BURNELL JM (1955). "The effect of acute respiratory acidosis on the internal equilibrium of potassium". J Clin Invest. 34 (8): 1276–85. doi:10.1172/JCI103174. PMC 438696. PMID 13242660.
  4. Conte G, Dal Canton A, Imperatore P, De Nicola L, Gigliotti G, Pisanti N; et al. (1990). "Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure". Kidney Int. 38 (2): 301–7. PMID 2402122.